Your browser doesn't support javascript.
loading
Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD.
Mandal, Jyotshna; Roth, Michael; Papakonstantinou, Eleni; Sun, Qingzhu; Costa, Luigi; Boeck, Lucas; Scherr, Andreas; Rakic, Janko; Louis, Renaud; Milenkovic, Branislava; Boersma, Wim; Kostikas, Konstantinos; Blasi, Francesco; Aerts, Joachim; Rohde, Gernot; Lacoma, Alicia; Torres, Antoni; Welte, Tobias; Tamm, Michael; Stolz, Daiana.
Afiliación
  • Mandal J; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Roth M; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Papakonstantinou E; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Sun Q; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Costa L; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Boeck L; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Scherr A; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Rakic J; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Louis R; Pneumology, University of Liege, Liege, Belgium.
  • Milenkovic B; Pneumology, Institute for Pulmonary Diseases, Belgrade, Serbia.
  • Boersma W; Department of Respiratory Diseases, Northwest Hospital Group, Alkmaar, The Netherlands.
  • Kostikas K; Pneumology, Medical School, University of Thessaly, Greece.
  • Blasi F; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Cardio-thoracic Unit and Cystic Fibrosis Adult Center Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano, Italy.
  • Aerts J; Pneumology, Amphia Hospital, Breda, The Netherlands.
  • Rohde G; Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Lacoma A; Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias (CIBERES) Instituto de Salud Carlos III, Spain.
  • Torres A; Pneumology, Hospital Clinic, Barcelona, Spain.
  • Welte T; Pneumology, Medizinische Hochschule, Hannover, Germany.
  • Tamm M; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Stolz D; Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland. Electronic address: daiana.stolz@usb.ch.
Pulm Pharmacol Ther ; 48: 111-116, 2018 02.
Article en En | MEDLINE | ID: mdl-29066215
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibronectinas / Antagonistas Muscarínicos / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibronectinas / Antagonistas Muscarínicos / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Suiza